Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation

Cancer Investigation

Volumn 29, Issue 3, 2011, Pages 196-201

  Winter, Jochen ^a   Pantelis, Annette ^a   Reich, Rudolf ^a   Martini, Markus ^a   Kraus, Dominik ^a   Jepsen, Soeren ^a   Allam, Jean Pierre ^a   Novak, Natalija ^a   Wenghoefer, Matthias ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Cancer; Human beta defensin; Intraoral squamous cell carcinoma

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; MESSENGER RNA;

ADULT; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

BETA-DEFENSINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79951653955     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.543210     Document Type: Article

References (27)

1. Silverman, S. Jr. Oral Cancer, 4th edition. Hamilton: B. C. Decker, 1998, 25-33.
2. Chambers MS, Jacob RF. How carcinogens cause cancer. TexDent J 1994;111:13-19.
3. Wenghoefer M, Pesch B, Harth V, Broede P, Fronhoffs S, Landt O, Brüning, T, Abel J, Bolt HM, Herberhold C, Vetter H, Ko YD. Association between head and neck cancer and microsomal epoxide hydrolase genotypes. Arch Toxicol 2003;77(1):37-41. (Pubitemid 36056981)
4. Pindborg JJ. Oral Cancer and Precancer. Bristol: JohnWright and Sons, Ltd., 1980.
5. Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T, Wong DT. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 2002;38(3):235-243. (Pubitemid 34442544)
6. Bouquot JE. Epidemiology. In Pathology of the Head and Neck, D. G. Gnepp (ed.). New York: Churchill Livingstone, 1987;263-314.
7. Bouquot JE. Reviewing oral leukoplakia-clinical concepts for the 1990s. J Amer Dent Assoc 1991;122:80-82.
8. Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Bergé, S, Jepsen S, Winter J. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg 2008;37(7):660-663. (Pubitemid 351905974)
9. National Cancer Institute. SEER Brochure 2005. Bethesda, MD: Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, 2005. Available from: www.cancer. gov.
10. Wenghoefer M, Pantelis A, Dommisch H, Götz, W, Reich R, Bergé, S, Martini M, Allam JP, Jepsen S, Merkelbach-Bruse, S, Fischer HP, Novak N, Winter J. Nuclear hBD-1 accumulation inmalignant salivary gland tumours. BMC Cancer 2008;7:8, 290.
11. Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, Reich RH, Martini M, Bergé, S, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides and cytokines in the development of oral leukoplakia. Oral Surg OralMed Oral Pathol Oral Radiol Endod 2010;110(3):351-356.
12. Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse, S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 2009;45(6):526-530.
13. Kesting MR, Loeffelbein DJ, Hasler RJ, Wolff KD, Rittig A, Schulte M, Hirsch T, Wagenpfeil S, Jacobsen F, Steinstraesser L. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest 2009;27(5):575-581.
14. Dommisch H, Acil Y, Dunsche A, Winter J, Jepsen S. Differential gene expression of human beta-defensins (hBD-1,-2,-3) in inflammatory gingival diseases. Oral Microbiol Immunol 2005;20(3):186-190. (Pubitemid 40559432)
15. Dommisch H, Winter J, Willebrand C, Eberhard J, Jepsen S. Immune regulatory functions of human beta-defensin-2 in odontoblast-like cells. Int Endod J 2007;40(4):300-307.
16. Dunsche A, Acil Y, Dommisch H, Siebert R, Schroder JM, Jepsen S. The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 2002;110(2):121-124.
17. Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest 2003;83(4):501-505. (Pubitemid 36457704)
18. Sun CQ, Arnold R, Fernandez-Golarz, C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. Human {beta}-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006;66(17):8542-8549. (Pubitemid 44449167)
19. Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol 2009;24:353-360.
20. Yoshimoto T, Yamaai T, Mizukawa N, Sawaki K, Nakano M, Yamachika E, Sugahara T. Different expression patterns of betadefensins in human squamous cell carcinomas. Anticancer Res 2003;23:4629-4633. (Pubitemid 38173877)
21. Mizukawa N, Sawaki K, Yamachika E, Fukunaga J, Ueno T, Takagi S, Sugahara T. Presence of human beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 2000;20:2005-2007. (Pubitemid 30636173)
22. Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, Sugahara T. High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 2002;22:2103-2107. (Pubitemid 34857029)
23. Nishimura M, Abiko Y, Kurashige Y, Takeshima M, Yamazaki M, Kusano K, Saitoh M, Nakashima K, Inoue T, Kaku T. Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. J Dermatol Sci 2004;26:87-95. (Pubitemid 39424131)
24. Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF, McCray, PB, Jr. Production of beta-defensin antimicrobial peptides by the oralmucosa and salivary glands. Infect Immun 1999;67(6):2740-2745. (Pubitemid 29244685)
25. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002-2007.
26. Kwasar HI, Ghosh SK, Hirsch SA, Koon HB, Weinberg A, Jin G. Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor beta. Peptides 2010;31:195-201.
27. Abiko Y, Mitamura J, Nishimura M, Muramatsu T, Inoue T, Shimono M, Kaku T. Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett 1999;143:37-43. (Pubitemid 29327187)